Atul Sharma
Atul Sharma
Professor of Medical Oncology,All India Institute of Medical Sciences, New Delhi
Verified email at
Cited by
Cited by
Best supportive care compared with chemotherapy for unresectable gall bladder cancer: a randomized controlled study
A Sharma, AD Dwary, BK Mohanti, SV Deo, S Pal, V Sreenivas, V Raina, ...
J Clin Oncol 28 (30), 4581-4586, 2010
Clinical features and prognostic factors of early breast cancer at a major cancer center in North India.
V Raina, M Bhutani, R Bedi, A Sharma, SVS Deo, NK Shukia, BK Mohanti, ...
Indian journal of cancer 42 (1), 2005
Febrile neutropenia in haematological malignancies.
A Sharma, N Lokeshwar
Journal of postgraduate medicine 51, 2005
Chemotherapy alone vs. chemotherapy plus high dose multiple antioxidants in patients with advanced non small cell lung cancer
AK Pathak, M Bhutani, R Guleria, S Bal, A Mohan, BK Mohanti, A Sharma, ...
Journal of the American College of Nutrition 24 (1), 16-21, 2005
Pigmentary changes in chronic myeloid leukemia patients treated with imatinib mesylate
B Arora, L Kumar, A Sharma, J Wadhwa, V Kochupillai
Annals of oncology 15 (2), 358-359, 2004
Chloroquine and Hydroxychloroquine for the Treatment of COVID-19: a Systematic Review and Meta-analysis
A Elavarasi, M Prasad, T Seth, RK Sahoo, K Madan, N Nischal, M Soneja, ...
Journal of general internal medicine, 1-7, 2020
Lactobacillus brevis CD2 lozenges reduce radiation- and chemotherapy-induced mucositis in patients with head and neck cancer: A randomized double-blind …
A Sharma, GK Rath, SP Chaudhary, A Thakar, BK Mohanti, S Bahadur
European Journal of Cancer 48 (6), 875-881, 2012
Infections in acute myeloid leukemia: an analysis of 382 febrile episodes
A Gupta, M Singh, H Singh, L Kumar, A Sharma, S Bakhshi, V Raina, ...
Medical Oncology 27 (4), 1037-1045, 2010
Concomitant chemoradiation versus radical radiotherapy in advanced squamous cell carcinoma of oropharynx and nasopharynx using weekly cisplatin: a phase II randomized trial
A Sharma, BK Mohanti, A Thakar, S Bahadur, S Bhasker
Annals of oncology 21 (11), 2272-2277, 2010
Flow cytometric immunophenotyping and minimal residual disease analysis in multiple myeloma
R Gupta, A Bhaskar, L Kumar, A Sharma, P Jain
American journal of clinical pathology 132 (5), 728-732, 2009
Adrenal involvement in non-Hodgkin's lymphoma: four cases and review of literature
D Singh, L Kumar, A Sharma, M Vijayaraghavan, S Thulkar, N Tandon
Leukemia & lymphoma 45 (4), 789-794, 2004
Cutaneous metastases of lung cancer.
R Kamble, L Kumar, V Kochupillai, A Sharma, MS Sandhoo, BK Mohanti
Postgraduate medical journal 71 (842), 741-743, 1995
Profile of infections and outcome in high-risk febrile neutropenia: experience from a tertiary care cancer center in India
I Ghosh, V Raina, L Kumar, A Sharma, S Bakhshi, S Thulkar, A Kapil
Medical Oncology 29 (2), 1354-1360, 2012
Significantly reduced regulatory T cell population in patients with untreated multiple myeloma
R Gupta, P Ganeshan, M Hakim, R Verma, A Sharma, L Kumar
Leukemia research 35 (7), 874-878, 2011
Prevalence and trends of human papillomavirus in oropharyngeal cancer in a predominantly north Indian population
A Bahl, P Kumar, L Dar, BK Mohanti, A Sharma, A Thakar, V Karthikeyan, ...
Head & neck 36 (4), 505-510, 2014
Gastric cancer in India
A Sharma, V Radhakrishnan
Indian Journal of Medical and Paediatric Oncology 32 (1), 12, 2011
Analysis of 2167 head and neck cancer patients' management, treatment compliance and outcomes from a regional cancer centre, Delhi, India
BK Mohanti, P Nachiappan, RM Pandey, A Sharma, S Bahadur, A Thakar
The Journal of Laryngology & Otology 121 (1), 49-56, 2007
A phase II study of gemcitabine and oxaliplatin (Oxigem) in unresectable gall bladder cancer
A Sharma, B Mohanti, V Raina, N Shukla, S Pal, A Dwary, S Deo, P Sahni, ...
Cancer chemotherapy and pharmacology 65 (3), 497, 2010
Symptom burden and quality of life in advanced head and neck cancer patients: AIIMS study of 100 patients
AK Gandhi, S Roy, A Thakar, A Sharma, BK Mohanti
Indian journal of palliative care 20 (3), 189, 2014
CD68 tumor-associated macrophage marker is not prognostic of clinical outcome in classical Hodgkin lymphoma
S Kayal, S Mathur, AK Karak, L Kumar, A Sharma, S Bakhshi, V Raina
Leukemia & lymphoma 55 (5), 1031-1037, 2014
The system can't perform the operation now. Try again later.
Articles 1–20